We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Consumer Sensors Could Drastically Reduce Cost of Biomedical Imaging

By MedImaging International staff writers
Posted on 07 Dec 2015
Print article
Image: Phase information contained in six of the 50 light frequencies analyzed by the system (Photo courtesy of MIT).
Image: Phase information contained in six of the 50 light frequencies analyzed by the system (Photo courtesy of MIT).
A new study reveals how mathematical modeling could enable biomedical imaging systems to use a simple depth sensor to approximate the measurements of expensive lab equipment.

Developed by researchers at the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA), the imaging system is based on a technique called fluorescence lifetime imaging (FLI), which also has applications in DNA sequencing and cancer diagnosis. And while traditional FLI uses light bursts in the picosecond range, and FLI time in biomedical imaging is in nanosecond range, off-the-shelf depth sensors (like the Microsoft Kinect) use light bursts that last tens of nanoseconds, far too coarse for to biomedical FLI.

The MIT researchers, however, were able to extract additional information from the fluorescent light signal by subjecting it to a Fourier transform, breaking it into its constituent frequencies. The optical signal returning from a biological sample is the sum of 50 different frequencies, which enabled the researchers to recover information from FLI bursts shorter than actual duration of the emitted burst of light. They did so by calculating each phase shift using a mathematical model of the overlapping intensity profiles of both the reflected and re-emitted light.

Once the deduced intensity profile of the reflected light is known, the distance between the emitter and the sample can be calculated. So unlike conventional FLI, the researchers' approach does not require calibration. To test the model, the researchers used commercial depth sensors that cost USD 100 with arrays of roughly 20,000 light detectors each. They found that while the setup does not afford the image resolution of existing FLI microscopes, it was good enough for some purposes to replace USD 100,000 lab equipment with denser arrays. The study was published in the November 20, 2015, issue of Optica.

“The theme of our work is to take the electronic and optical precision of this big expensive microscope and replace it with sophistication in mathematical modeling,” said lead author Ayush Bhandari, MSc, a graduate student at the MIT Media Lab. “We show that you can use something in consumer imaging, like the Microsoft Kinect, to do bioimaging in much the same way that the microscope is doing.”

FLI measures that interval—the lifetime of the fluorescence event—in a biological sample treated with a fluorescent dye to reveal information about the sample's chemical composition, since for any given fluorophore, interactions with other chemicals will shorten the interval between the absorption and emission of light in a predictable way.

Related Links:

Massachusetts Institute of Technology


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Pre-Op Planning Solution
Sectra 3D Trauma
PACS Workstation
CHILI Web Viewer
New
Ultrasound System
Acclarix AX9

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.